<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/80392F0C-23A4-449D-BC8D-4D77C0F53303"><gtr:id>80392F0C-23A4-449D-BC8D-4D77C0F53303</gtr:id><gtr:name>Mahidol University</gtr:name><gtr:address><gtr:line1>Mahidol University</gtr:line1><gtr:line2>Office of the President  Mahidol Univers</gtr:line2><gtr:line3>25/25 Moo 3, Phuttamonthon 4 Road</gtr:line3><gtr:postCode>73170</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F0DDF24E-7698-449D-BF5C-2B2BB0DD500A"><gtr:id>F0DDF24E-7698-449D-BF5C-2B2BB0DD500A</gtr:id><gtr:firstName>Gavin</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Screaton</gtr:surname><gtr:orcidId>0000-0002-3549-4309</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D0FBCD69-3D31-413A-AD7E-8E4502CA6369"><gtr:id>D0FBCD69-3D31-413A-AD7E-8E4502CA6369</gtr:id><gtr:firstName>Bernard</gtr:firstName><gtr:otherNames>Vincent</gtr:otherNames><gtr:surname>North</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/898FEB26-C34F-4C00-BD46-D8444A99EC6F"><gtr:id>898FEB26-C34F-4C00-BD46-D8444A99EC6F</gtr:id><gtr:firstName>Juthathip</gtr:firstName><gtr:surname>Mongkolsapaya</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801508"><gtr:id>17773FC5-1840-4366-9300-140C31512D9C</gtr:id><gtr:title>Biomarkers to predict severity in dengue infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801508</gtr:grantReference><gtr:abstractText>Dengue is a mosquito bourne viral infection of the tropics and subtropics. It can lead to a severe haemorrhagic fever that can be fatal unless treated in hospital. At the early stages it is impossible to judge which patients are going to suffer the more severe symptoms and should be admitted to hospital. During epidemics literally thousands of cases can occur at the same time and completely overwhelm the hospital systems. This research aims to develop a simple predictor of disease severity which would allow the high risk patients to be admitted to hospital whilst those at lower risk could be managed at home.</gtr:abstractText><gtr:technicalSummary>Dengue virus is an emerging infectious disease the incidence of which is still increasing alarmingly. Most dengue infections are either asymptomatic or mild referred to as dengue fever (DF). However 1-5% of infections can lead to dengue haemorrhagic fever (DHF) that is characterised by a severe vascular leak that can lead to hypovolaemic shock haemorrhage and death. Untreated this condition can be fatal in about 20% whilst expert hospital treatment which consists mainly of careful fluid replacement and monitoring reduces mortality to well below 1%. Dengue puts a huge stress on the healthcare systems in developing countries where explosive outbreaks can literally overwhelm the hospital systems. An effective early test which would stratify patients into high and low risk of developing haemorrhagic fever would be very useful to target the high risk group for hospital admission. It may also have future utility in directing antiviral drug therapy should the current anti-dengue drug programmes come to fruition. At present there is no such early test before the relatively abrupt onset of the vascular leak and shock.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>576025</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mahidol University</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:department>Siriraj Hospital</gtr:department><gtr:description>Dengue clinical centres</gtr:description><gtr:id>479F71F7-FD2E-4851-AF52-AACF5BC1E50E</gtr:id><gtr:impact>publications</gtr:impact><gtr:outcomeId>hf6c7vsEapZ-1</gtr:outcomeId><gtr:partnerContribution>Sample collection and processing</gtr:partnerContribution><gtr:piContribution>We get our samples from Thailand to measure biomarkers</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Felix Rey</gtr:description><gtr:id>33D28FF8-818B-4830-9D9C-F5E56A56A9E6</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>dbp9hGbaPa9-1</gtr:outcomeId><gtr:partnerContribution>Felix Rey at Pasteur solves the structures of antibodies bound to dengue antigens</gtr:partnerContribution><gtr:piContribution>We make monoclonal antibodies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Grand Challenges conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>11368570-E201-448C-A145-C1F8600240ED</gtr:id><gtr:impact>Grand Challenges conference in Beijing, China. I was invited on behalf of the Bill &amp;amp; Melinda Gates Foundation as a speaker to present my work. The Forum was a convening of over 750 key leaders from across the global community to share best practices, encourage collaboration and seek solutions for common challenges. The meeting aimed to build momentum for global health and development innovation and foster scientific collaboration among international groups and researchers. It was co-hosted by the Ministry of Science &amp;amp; Technology, Grand Challenges Canada, the United States Agency for International Development (USAID), Wellcome Trust, the Bill &amp;amp; Melinda Gates Foundation, along with others.</gtr:impact><gtr:outcomeId>58b6a9ec78fa54.90507345</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>33rd Annual Meeting of the Nordic Society of Clinical Microbiology and Infectious Diseases in Finland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>819CB533-274C-417E-9A1E-42B6A9842D94</gtr:id><gtr:impact>I was invited to present my work by the The Nordic Society of Clinical Microbiology and Infectious Diseases.the main topic was to discuss ways to tackle anti-microbial resistance. The first part of the discussion was focused on increased resistance and decreased option and how we can tackle this global issue. I gave my talk on human anti-body responses.</gtr:impact><gtr:outcomeId>58bd5846bf0530.11868715</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the International meeting on Arboviruses and Their Vectors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8533D2E4-1230-4152-849F-9FEDB75E5114</gtr:id><gtr:impact>This was a meeting organised by the Society for General Microbiology and the focus of the meeting was on arboviruses and their vectors. Topics such as Interactions of flaviviruses with mosquito vectors and Arboviruses in the conquest of Europe were discussed and spoken about. I presented my work on The human antibody response to dengue virus infection.</gtr:impact><gtr:outcomeId>58ac59ffc02621.37698872</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal College of Physicians Advance Medicine Conference - Key Note Speaker and chaired an session</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D7D99AAE-0341-45D5-A184-0310F1F5A85B</gtr:id><gtr:impact>The conference was on advance medicine.Topics revolved around Infectious Disease: Chronic Viral Infection, Advances in Hepatitis C , Tuberculosis, Clinical Implications of the Global MDR TB epidemic, Diagnosis and treatment of HIV associated TB, The worldwide threat of emerging infections: update on Dengue Haemorrhagic Fever and other topics replated to Infectious diseases.</gtr:impact><gtr:outcomeId>58ac58bd556128.31822808</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Congress on Medical Virology 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>631D797E-6AAC-4C8F-AB56-81C6F0C4778C</gtr:id><gtr:impact>I lectured on protective and pathogenic immunity in dengue virus infection and it sparked questions.

N.A.</gtr:impact><gtr:outcomeId>5461ee65b430a1.61457450</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.icmv2014.com/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the British Society of Immunology Annual Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>12DDB03D-C6EB-468C-8657-27199E31D411</gtr:id><gtr:impact>The purpose was to present my research, meet other researchers and share information and best practice and forge further collaborations.</gtr:impact><gtr:outcomeId>58ac57f308e676.26567762</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ASID 2016 Annual Scientific Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5BBC360A-D433-4A61-A657-E8F4AAF348EB</gtr:id><gtr:impact>I was invited to speak at the meeting on my work and also chair a session which I did.I gave my presentation on 'The Antibody Response in Dengue Virus Infection' and chaired the session on 'Antibiotics &amp;amp; Sepsis'. Many professional practitioners, medical students and policy makes alike attended this meeting. As did researchers which was great for further research networking and collaboration.</gtr:impact><gtr:outcomeId>58bd55afc09485.15381841</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Global Heath Research annual meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E7455A96-67F8-4AB9-9761-DBD40D50A583</gtr:id><gtr:impact>Annual update of the centre and progress 
Collaboration and capacity development 
Research into health problems of the Southern African Region
Global Health Issues

Public Health benefits and research benefits</gtr:impact><gtr:outcomeId>5463696783f088.05888029</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/centres/globalhealth/eventssummary/event_10-10-2014-16-31-14</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GSK Vaccines conference</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1A1FAD67-5253-47A2-B5D4-BD4F158A9D3F</gtr:id><gtr:impact>I co-presented my research on vaccine development with one of my collaborators, Prof Felix Rey from Institut Pasteur in Paris. We did a joint a joint seminar on &amp;quot;Certain antibodies isolated from dengue patients not only neutralise all four dengue serotypes, but also Zika virus, providing a structural basis for an epitope-focused vaccine design against both viruses&amp;quot;, and met some key people regarding discussion on further vaccine development.</gtr:impact><gtr:outcomeId>58bd56d621fef6.24758129</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Guest Lecturer at the UK Society for Microbiology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E5AD7FEE-AE16-4664-8259-F3951498EE89</gtr:id><gtr:impact>I was invited to present my work as a guest lecturer at the UK Society for Microbiology in Liverpool. The focus of the conference was Viral haemorrhagic fevers such as Ebola, Zika and Dengue and I presented my work on the Broadly-neutralising antibodies to dengue virus to inform research and policy making.</gtr:impact><gtr:outcomeId>58b6eaed764109.45561343</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WHO and NIAID Consultation on Zika Virus Vaccine Development</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C0AE5616-1A82-47DE-BF0C-CD0CD163FCD0</gtr:id><gtr:impact>I was invited to USA by the World Health Organisation to present my work on Immune Responses is Dengue and Zika Viruses.</gtr:impact><gtr:outcomeId>58bd6211327b63.13274606</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Chain Florey Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9D1BD0C7-15DF-4374-8538-940133695DE7</gtr:id><gtr:impact>the seminars brought latest trends to light

Views on personalised medicine the future</gtr:impact><gtr:outcomeId>54636a1b399298.17906912</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CIDRI Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4D827B5D-D562-4EBE-A323-DEE69E630182</gtr:id><gtr:impact>Meeting with Prof Bongani M. Mayosi, Head, DoM , UCT
Meeting with Prof Willem (Wim) de Villiers, Dean of Health Sciences, UCT
Meeting with Valerie Mizrahi, Director of IDM (Inst. of ID &amp;amp; Molecular Med)
 Talks sparked questions and there were extensive discussions
better understanding of Research Entry awards available to scientists

Improvement of clinical and laboratory facilities for patients and staff.
Further work on co-ordinate research meetings within Africa and facilitate international networking for the benefit of all researchers especially the awardees has been initiated.</gtr:impact><gtr:outcomeId>54636d985a7ce8.03384784</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.cidri.uct.ac.za/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presented at the International Symposium on Flaviviruses</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>51CC1A7F-5A51-4DB5-B7BF-88189260271C</gtr:id><gtr:impact>This was an international symposium on Flaviviruses - Structure and Immunity. There were both oral presentations as well as poster sessions. Many national and international researchers presented their work as did I.</gtr:impact><gtr:outcomeId>58ac5b1c4ab411.07645036</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presented at the 3rd Annual DENFREE Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>832DBBC9-99AE-4AC4-9206-9FDEB79C7B2E</gtr:id><gtr:impact>I presented my work at the 3rd Annual DENFREE Meeting. This was co-hosted by Pasteur Institute, Paris and DENFREE - Dengue Research Framework for resisting epidemics in Europe. It highlighted the trends in immunology, spoke about what had been achieved so far and what was in store for the future, looked at viral genetic markers, studied the impact on various countries like Bangkok, Cuba and even the US Dengue challenge.</gtr:impact><gtr:outcomeId>58b6e864087c95.51851239</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Uncovered - Natural History Museum (September 2013)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A6BF7EA0-452A-4D76-9D29-6BB8A9E1CB6D</gtr:id><gtr:impact>Science Uncovered is a widely-advertised and well-attended public outreach event hosted at the Natural History Museum in London, where scientist engage with the public face-to-face basis to discuss their research and its implications in an informal setting. I represented Imperial College London, accompanied by two PhD students, and discussed my group's work, which included the current grant, under the general theme of ecological responses and alterations to energy flux in food webs due to environmental stressors. At our stall we spoke to several hundred visitors throughout the day.

See description above.</gtr:impact><gtr:outcomeId>r-4215332199.08860730c9cf6a4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presented and participated in the Zika Virus Conference in Recife, Barzil</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4B1B0448-A71F-40AE-9F2F-FD240DC0E941</gtr:id><gtr:impact>I was invited on behalf of CPqAM/Fiocruz, Recife Pernambuco, to participate in the Workshop (ABCDE do Zika Virus). They had put together experts in epidemiology, basic science,
entomologist and other related areas to discuss the recent epidemic of Zika v&amp;iacute;rus in Brazil which was threatening to become an international health problem.</gtr:impact><gtr:outcomeId>58b6e93f083a07.77445270</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Researchers' meeting: Immunology &amp; Infectious Diseases</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>545039EC-FA4C-492D-BD3C-EAB8E6346502</gtr:id><gtr:impact>This is an annual meeting for all PIs and I presented my work and progress at this meeting. Other researchers and professional practitioners were also present and it aided with research trends, making informed decisions and reporting progress as well a further collaboration and funding opportunities.</gtr:impact><gtr:outcomeId>58bd5631bde151.23516719</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multiscale Dynamics Dengue and Zika Virus Conference</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1C16B5A5-E1F1-494C-8674-5AD68EAB7DDA</gtr:id><gtr:impact>I was invited to speak and present my research at this conference which was organised by Shee-&amp;shy;Mei Lok and Paul Matsudaira,jointly supported by the Centre for BioImaging Sciences in NUS, the Duke-&amp;shy;NUS Medical School and the Singapore Ministry of Education. Topics ranged fro control and detection to immunity, genome and structural studies.</gtr:impact><gtr:outcomeId>58bd61ad3675f9.92261055</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the Courage Fund for Infectious Diseases</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EBF30F32-B40D-470A-8F8A-326C35E86FD5</gtr:id><gtr:impact>This was a conference where I presented on the human antibody response in dengue virus infection. it sparked questions afterwards and let to networking.</gtr:impact><gtr:outcomeId>58ac593f94a865.42445652</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Division of Infectious Diseases Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8B3A48CE-890E-4417-AC4B-24A060E15D21</gtr:id><gtr:impact>Piecing together the Puzzle of Severe Malaria
Keynote presentation: Prof David Salisbury, Head of Immunisation, Public Health England
Latest trends in Infectious diseases

Better understanding of latest trends in Infectious diseases</gtr:impact><gtr:outcomeId>54636e61afecb9.21427363</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview With BBC</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>BE8082BB-98CE-4DC5-9F3C-2D9DC27E0FFC</gtr:id><gtr:impact>Spread of Knowledge on Dengue

Higher interest Dengue Virus and more awareness</gtr:impact><gtr:outcomeId>iVWPpqqNnrF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of Physicians annual meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>38DD61A9-3410-47B4-9F00-43C36F5CE3B3</gtr:id><gtr:impact>Latest trends in medicine

knowledge of latest trends in medicine</gtr:impact><gtr:outcomeId>54636c0dcd78d5.27140513</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust: Researcher Meeting: Public Health and Tropical Diseases</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>80BE6376-C477-4F7B-A1AC-3DC22E376100</gtr:id><gtr:impact>I gave a talk on Dengue Virus which sparked questions afterwards and I have been invited for further conferences.

I have been invited for further conferences</gtr:impact><gtr:outcomeId>54636b6763b600.92101747</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nature Conference Viral Infection and Immune Response</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>736B340F-FD66-41FF-AD8E-2C176E2C1CC7</gtr:id><gtr:impact>I was invited by Wuhan university who held a talk in partnership with Nature Communications to give a talk on my research in immune responses and viral infection. Presentation covered a wide range of topics from Epidemiology of emerging viral disease, Immune intervention and prevention of disease, Persistent viral infection and immune dysregulation to Induction of systemic adaptive immunity. There were also key note speeches given by leading researchers and poster sessions - all of which was very informative.</gtr:impact><gtr:outcomeId>58bd59aa58dd76.80392576</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Staff Rounds</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5B56ED13-CF1D-4A8E-AD55-77AF85725F1E</gtr:id><gtr:impact>About 80 health professionals attend these rounds weekly. The presentations are given by different divisions each week and highlight the latest trends in medicine.

Keeping abrest with the latest in medicine and continued professional development.</gtr:impact><gtr:outcomeId>a3X444UoNM4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Co-Chair the MRC Newton Fund, UK-Indonesia: Joint Health Research Call Panel - Research Call on Infectious Diseases</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D9E91AD0-7C55-4EDD-AED3-5877ED2E5C19</gtr:id><gtr:impact>This was a meeting to review funding.</gtr:impact><gtr:outcomeId>58b6ec88d02850.16228128</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society for Immunology Congress 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>21C4E7B7-FD7B-4E4A-83E2-4C90FFDB5A60</gtr:id><gtr:impact>British Society for Immunology Congress 2013 in Liverpool from 2nd to 5th December. Title was &amp;quot;Protective and pathogenic immunity in dengue virus infection&amp;quot;.

Generated interest.</gtr:impact><gtr:outcomeId>kfTpUTBHW5T</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.bsicongress.com</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at the Virology Seminar Series at University College London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8100DDD2-F68F-4DDD-8BF8-5E9B6BBC5E3C</gtr:id><gtr:impact>I gave a talk at UCL on my research in Dengue and Zika viruses.</gtr:impact><gtr:outcomeId>58b6aa7735e089.17807968</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Participated in a workshop on immune correlates for dengue</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1DD9E8A7-0E32-49BC-B70C-7FB60514C516</gtr:id><gtr:impact>I participated in the immune correlates for dengue workshop organised by the PDC - Partnership for Dengue Control and presented on The role of highly neutralizing, cross-reactive antibodies/epitopes. The overall objective was to generate consensus on the current understanding of the immune response to and protection from dengue virus infection, identify key unanswered questions, and address how to improve measurement of efficacy in vaccine trials.</gtr:impact><gtr:outcomeId>58b6ea2372ddd9.13949430</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Wellcome Trust Enhancement Fund</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>203158/Z/16/Z</gtr:fundingRef><gtr:id>F44723D6-63E0-4252-B69A-BE386D295701</gtr:id><gtr:outcomeId>58b6e6676c4d06.19369241</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>494207</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>DENFREE - Dengue research framework for resisting epidemics in Europe</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>B806E8D0-96AD-489A-BA19-917487A0F913</gtr:id><gtr:outcomeId>56dd70ea12cfc5.10896453</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Investigator</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>ACF09F45-A8CD-43D5-8AAC-C9EF71BF9636</gtr:id><gtr:outcomeId>M5oNp9Vr6ZW</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grants</gtr:description><gtr:end>2007-04-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>8AC7DBD0-E7B0-4F9F-98AA-ACD4F729149C</gtr:id><gtr:outcomeId>DA18276F9820</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2004-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomarkers grant</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E87F1247-E825-4180-BAAF-DBF129BD5327</gtr:id><gtr:outcomeId>4574A29CD1C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>HVBD DART 2013 First International Symposium on Human Vector-Borne Diseases Satellite Symposium</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>B1167284-B53E-4365-A725-2C29DDCCA23D</gtr:id><gtr:outcomeId>dgkoNnnTJ6h</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Centre for Clinical Tropical Medicine/Global Health Research annual meeting 2013</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3C709565-07B0-4B72-8D4D-4C509C57E66B</gtr:id><gtr:impact>Understanding Dengue pathogenesis and prospects for vaccine</gtr:impact><gtr:outcomeId>QNy9rGugwKd</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>World Innovation Summit for Health</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>45AA3FAE-90A9-44E8-8EC2-6DFB7CE475A9</gtr:id><gtr:outcomeId>KdgX6Gar6nP</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FAEC1AAB-3A1D-46B1-B1FE-EBDD46CB30CC</gtr:id><gtr:title>The immunopathology of dengue and Zika virus infections.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9324b0be55d7eb2d2992e62ffceeb4e"><gtr:id>c9324b0be55d7eb2d2992e62ffceeb4e</gtr:id><gtr:otherNames>Culshaw A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>5aa7a931bb8e19.11291071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5E50FB1-9969-440C-A22E-ED87790ABF3C</gtr:id><gtr:title>Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8T cell response.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9324b0be55d7eb2d2992e62ffceeb4e"><gtr:id>c9324b0be55d7eb2d2992e62ffceeb4e</gtr:id><gtr:otherNames>Culshaw A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5aa7a933f14d73.18126980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>858D45A0-08B2-4167-A08E-EC251E4A0FB3</gtr:id><gtr:title>Antibodies and tuberculosis.</gtr:title><gtr:parentPublicationTitle>Tuberculosis (Edinburgh, Scotland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8f652ecc13085fce6584f220c0089a9"><gtr:id>d8f652ecc13085fce6584f220c0089a9</gtr:id><gtr:otherNames>Jacobs AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-9792</gtr:issn><gtr:outcomeId>58b6e5883e83a1.08237717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6A32C49-64B5-4E50-8B41-447AC31197D8</gtr:id><gtr:title>Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58ac546fd66961.05829339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B41688A-1358-425A-BF8F-BA95BEF2A2D4</gtr:id><gtr:title>Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36299e25d361f3a506a3aa377ee12437"><gtr:id>36299e25d361f3a506a3aa377ee12437</gtr:id><gtr:otherNames>Watson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56dd63e50ecb72.11467982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78765DDD-F97B-4FE9-8ED2-EDD9E0DF7FA6</gtr:id><gtr:title>Complement alternative pathway genetic variation and Dengue infection in the Thai population.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/386eedd87061ad6154faa3f4aa3eb0a8"><gtr:id>386eedd87061ad6154faa3f4aa3eb0a8</gtr:id><gtr:otherNames>Kraivong R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>56dd62fe0e1749.96889418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A51D2F83-7427-4915-9A97-1FFEFD312F61</gtr:id><gtr:title>Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af15431fa34ac896e6a43fdb8ac4c9ed"><gtr:id>af15431fa34ac896e6a43fdb8ac4c9ed</gtr:id><gtr:otherNames>D?cembre E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56dd62af2a0ce1.83055223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70A4969E-0EDF-4D85-B121-184D155E01A9</gtr:id><gtr:title>Recognition determinants of broadly neutralizing human antibodies against dengue viruses.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c031b5eaaf37d25bcbf7f60664e712c"><gtr:id>6c031b5eaaf37d25bcbf7f60664e712c</gtr:id><gtr:otherNames>Rouvinski A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56dd60cc30b388.06877781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D4ABEAA-B89F-4C1B-AC35-C63277B2C70C</gtr:id><gtr:title>Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70757d4f43d859ae837579a97bdeb00f"><gtr:id>70757d4f43d859ae837579a97bdeb00f</gtr:id><gtr:otherNames>Li D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56dd649bbae8b7.07625414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37F82FE1-3D62-4059-9C4A-215CD5CC9DBD</gtr:id><gtr:title>Evolution of neurovirulent Zika virus.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db9055b9d654d1ad5a92d6548d2a1bb"><gtr:id>9db9055b9d654d1ad5a92d6548d2a1bb</gtr:id><gtr:otherNames>Screaton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5aa7a934ac9f24.89869817</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E51B13BB-D439-4CEA-9DA2-4C08367FE263</gtr:id><gtr:title>Endothelial Nitric Oxide Pathways in the Pathophysiology of Dengue: A Prospective Observational Study.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>5aa7a9335e2b90.33604386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1F1AF43-893E-4A3E-A6FA-FA388B38BE1F</gtr:id><gtr:title>MAIT cells are activated during human viral infections.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd9c5d3ad67e5b8adc8f4409ebdea785"><gtr:id>fd9c5d3ad67e5b8adc8f4409ebdea785</gtr:id><gtr:otherNames>van Wilgenburg B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58ac546f70bc37.78204478</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>512ADDE5-E562-4524-82E8-BB8EC73342F1</gtr:id><gtr:title>High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fca4d2dc6e8382637b27d16998739126"><gtr:id>fca4d2dc6e8382637b27d16998739126</gtr:id><gtr:otherNames>Tsai WY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56dd62fdd6f869.95215043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D363446C-DD0C-4505-90A9-21EE850FC5B3</gtr:id><gtr:title>Recent advances in understanding dengue.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>58ac540b700634.69609494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0868A1D4-A11B-4F06-98F1-CF5118484B97</gtr:id><gtr:title>New insights into the immunopathology and control of dengue virus infection.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9db9055b9d654d1ad5a92d6548d2a1bb"><gtr:id>9db9055b9d654d1ad5a92d6548d2a1bb</gtr:id><gtr:otherNames>Screaton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>58ac53b697b2c9.44491429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7D30A1B-2056-44A8-A6F5-3FE096B9A44D</gtr:id><gtr:title>An in-depth analysis of original antigenic sin in dengue virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10ed0f78d99370f902a6926e13983a6b"><gtr:id>10ed0f78d99370f902a6926e13983a6b</gtr:id><gtr:otherNames>Midgley CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56dd63e555c1c3.22079032</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAF4E943-CB6F-4BCA-BACF-BA1B4E294A83</gtr:id><gtr:title>The immunology of Zika Virus.</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9324b0be55d7eb2d2992e62ffceeb4e"><gtr:id>c9324b0be55d7eb2d2992e62ffceeb4e</gtr:id><gtr:otherNames>Culshaw A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>5aa7a934e1f851.64068833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAEE0F5F-38D8-4D67-B253-60CF25B4E8E4</gtr:id><gtr:title>Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef09853ab0d3d6e1c4e6061dbf5917d2"><gtr:id>ef09853ab0d3d6e1c4e6061dbf5917d2</gtr:id><gtr:otherNames>Fernandez E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5aa7a9347085c2.13359698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E075854B-DADD-4A69-96F9-5BCD4E6F3BB8</gtr:id><gtr:title>Association of Microvascular Function and Endothelial Biomarkers With Clinical Outcome in Dengue: An Observational Study.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>58ac546f36f1a8.06272366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4533D242-5D0A-4D8E-AB8F-BCACC5084DF0</gtr:id><gtr:title>Cardio-haemodynamic assessment and venous lactate in severe dengue: Relationship with recurrent shock and respiratory distress.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5aa7a9330ccd54.87670144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE6A08F6-B77E-4358-A96E-787B6B762285</gtr:id><gtr:title>Remarkably low affinity of CD4/peptide-major histocompatibility complex class II protein interactions.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f35343efd6a5a8ddc873888ac57c309d"><gtr:id>f35343efd6a5a8ddc873888ac57c309d</gtr:id><gtr:otherNames>J?nsson P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58ac54266de312.88032098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A5B8BAF-0D92-47EC-836B-DD744959363A</gtr:id><gtr:title>The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39de87038ef33f889085a8a3b58da060"><gtr:id>39de87038ef33f889085a8a3b58da060</gtr:id><gtr:otherNames>Freundt EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56dd63e583fa94.33992116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EFB5267-B23B-42E5-B2F3-1139284FD80B</gtr:id><gtr:title>Synovial IL-21/TNF-producing CD4T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d93e20bb653711bec5e0ee4ed73e3839"><gtr:id>d93e20bb653711bec5e0ee4ed73e3839</gtr:id><gtr:otherNames>Lebre MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>58b6e587e26a58.38300852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36F684C4-B8BB-411C-B875-DD72CF89B690</gtr:id><gtr:title>A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1383435e43602a50e492d78c4647d72"><gtr:id>d1383435e43602a50e492d78c4647d72</gtr:id><gtr:otherNames>Dejnirattisai W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>56dd62639a6963.47103676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1C316D0-AFFC-4997-AE0A-01BD356A064D</gtr:id><gtr:title>Microvascular and endothelial function for risk prediction in dengue: an observational study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1ac033a4df3945c2f4707dddd3643e8"><gtr:id>c1ac033a4df3945c2f4707dddd3643e8</gtr:id><gtr:otherNames>Yacoub S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58ac537fbb75f8.47832090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDF1C441-D31D-4273-9008-64005DE9071D</gtr:id><gtr:title>Structural basis of potent Zika-dengue virus antibody cross-neutralization.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6be8fbe643ad7e1ee8e12b8c197087fb"><gtr:id>6be8fbe643ad7e1ee8e12b8c197087fb</gtr:id><gtr:otherNames>Barba-Spaeth G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58ac546fa524b1.82315031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD728EF9-AFA7-4B23-B1D3-AF8698201744</gtr:id><gtr:title>Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10ed0f78d99370f902a6926e13983a6b"><gtr:id>10ed0f78d99370f902a6926e13983a6b</gtr:id><gtr:otherNames>Midgley CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56dd63e4d45fa0.05128927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52CFCA82-B1CE-45F9-A479-9BA686E61CD1</gtr:id><gtr:title>Enhanced immune recognition of cryptic glycan markers in human tumors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e332ac0a0bc0f21fb78d7d529aa2302"><gtr:id>7e332ac0a0bc0f21fb78d7d529aa2302</gtr:id><gtr:otherNames>Newsom-Davis TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>56dd63e6206145.30448231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDE53222-3E5C-47DE-A973-FC5F89A61AF2</gtr:id><gtr:title>Recent advances in human flavivirus vaccines.</gtr:title><gtr:parentPublicationTitle>Current opinion in virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9965f8d1c7f9bf91c6f59947d5fd12e4"><gtr:id>9965f8d1c7f9bf91c6f59947d5fd12e4</gtr:id><gtr:otherNames>Scherwitzl I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1879-6257</gtr:issn><gtr:outcomeId>5aa7a933a138d3.03073698</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801508</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>